Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Eight new diagnostic codes were added to private reimbursement schedule in England in February 2018

The Clinical Coding and Schedule Development (CCSD) develops and maintains procedural and diagnostics nomenclature for private payers in England. Once codes are added to the Schedule, a rivate insurance company can develop reimbursement tariff for these procedures and tests.

The CCSD Group has approved the following diagnostic codes for publication to the CCSD Schedule in February:

  • CD-274 (PD-L1) mutation analysis (blood) (0025G);
  • CD-274 (PD-L1) mutation analysis (tumour) (0026G);
  • FoundationOne (0027G);
  • CD-279 (PD-1) mutation analysis (tumour) (0028G);
  • CD-279 (PD-1) mutation analysis (blood) (0029G);
  • B cell clonality (3009G);

 See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.